The Cabinet of Ministers has approved the Concept of Technological Development until 2030. This was reported on Thursday in the Telegram channel of the Russian...
Investigators of the Bryansk region opened a criminal case on negligence in providing preferential categories of citizens with subsidized medicines, medical devices and medical...
The first phase of construction of the Avexima pharmaceutical company plant, which will be located in Esipovo Industrial Park in Moscow-region Solnechnogorsk, is scheduled...
Generium, a Russian developer of biotechnological medicines, will supply its products to a number of countries of the Middle East and North Africa (MENA) region....
R-Pharm group and Kazan Federal University (KFU) signed an agreement on the development of an innovative gene therapy drug for the treatment of spinal...
More than 550,000 doses of Russian-made measles vaccine were released into civil circulation in the last decade of April, according to the press service...
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
